S&P 500   5,039.81 (-0.23%)
DOW   37,839.36 (+0.11%)
QQQ   427.46 (-0.84%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,039.81 (-0.23%)
DOW   37,839.36 (+0.11%)
QQQ   427.46 (-0.84%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,039.81 (-0.23%)
DOW   37,839.36 (+0.11%)
QQQ   427.46 (-0.84%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,039.81 (-0.23%)
DOW   37,839.36 (+0.11%)
QQQ   427.46 (-0.84%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
NASDAQ:CLOV

Clover Health Investments (CLOV) Stock Price, News & Analysis

$0.64
+0.02 (+2.67%)
(As of 01:39 PM ET)
Today's Range
$0.63
$0.65
50-Day Range
$0.63
$1.02
52-Week Range
$0.61
$1.63
Volume
4.84 million shs
Average Volume
9.17 million shs
Market Capitalization
$317.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50

Clover Health Investments MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
137.6% Upside
$1.50 Price Target
Short Interest
Healthy
8.88% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$100,010 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.20) to ($0.16) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.33 out of 5 stars

Medical Sector

468th out of 930 stocks

Hospital & Medical Service Plans Industry

8th out of 10 stocks

CLOV stock logo

About Clover Health Investments Stock (NASDAQ:CLOV)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

CLOV Stock Price History

CLOV Stock News Headlines

Warning: Biden’s revenge against Trump voters?
Is THIS Joe Biden’s planned revenge against Trump? Bumbling Biden will lose in November.
Warning: Biden’s revenge against Trump voters?
Is THIS Joe Biden’s planned revenge against Trump? Bumbling Biden will lose in November.
CLOV Mar 2024 2.000 call
CLOV Mar 2024 2.000 put
27 show home tricks and how to spot them
Q4 2023 Clover Health Investments Corp Earnings Call
Clover Health Q4 2023 Earnings Preview
Clover Health Investments's Earnings Outlook
Clover Health Investments A earnings: here's what Wall Street expects
CLOV Mar 2024 0.500 call
CLOV Mar 2024 0.500 put
See More Headlines
Receive CLOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/12/2024
Today
4/17/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
N/A
Current Symbol
NASDAQ:CLOV
Fax
N/A
Employees
552
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.50
High Stock Price Target
$1.50
Low Stock Price Target
$1.50
Potential Upside/Downside
+140.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-213,360,000.00
Pretax Margin
-10.49%

Debt

Sales & Book Value

Annual Sales
$2.03 billion
Book Value
$0.59 per share

Miscellaneous

Free Float
387,219,000
Market Cap
$309.56 million
Optionable
Optionable
Beta
1.84
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Vivek GaripalliMr. Vivek Garipalli (Age 45)
    Co-Founder & Executive Chairman
  • Mr. Andrew Toy (Age 45)
    Co-Founder, CEO & Director
    Comp: $1.01M
  • Mr. Brady Priest J.D. (Age 47)
    Chief Executive Officer of Home Care
    Comp: $587.36k
  • Mr. Terrence Ronan (Age 64)
    Interim CFO, Principal Financial Officer & Principal Accounting Officer
  • Mr. Conrad Wai (Age 43)
    Chief Technology Officer
  • Mr. Derrick L. Nueman
    Head of Investor Relations & Corporate strategy
  • Ms. Wendy Richey
    Chief Compliance Officer
  • Ms. Karen Soares
    General Counsel, Senior VP & Corporate Secretary
  • Ms. Rachel Fish
    Chief People Officer
  • Ms. Jamie L. Reynoso (Age 54)
    Chief Executive Officer of Medicare Advantage
    Comp: $461.74k

CLOV Stock Analysis - Frequently Asked Questions

Should I buy or sell Clover Health Investments stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares.
View CLOV analyst ratings
or view top-rated stocks.

What is Clover Health Investments' stock price target for 2024?

1 Wall Street research analysts have issued twelve-month price targets for Clover Health Investments' stock. Their CLOV share price targets range from $1.50 to $1.50. On average, they expect the company's stock price to reach $1.50 in the next year. This suggests a possible upside of 137.6% from the stock's current price.
View analysts price targets for CLOV
or view top-rated stocks among Wall Street analysts.

How have CLOV shares performed in 2024?

Clover Health Investments' stock was trading at $0.9521 at the beginning of 2024. Since then, CLOV stock has decreased by 33.7% and is now trading at $0.6312.
View the best growth stocks for 2024 here
.

Are investors shorting Clover Health Investments?

Clover Health Investments saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 43,980,000 shares, a decrease of 7.5% from the March 15th total of 47,540,000 shares. Based on an average daily volume of 9,360,000 shares, the days-to-cover ratio is presently 4.7 days.
View Clover Health Investments' Short Interest
.

When is Clover Health Investments' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our CLOV earnings forecast
.

How were Clover Health Investments' earnings last quarter?

Clover Health Investments, Corp. (NASDAQ:CLOV) announced its earnings results on Tuesday, March, 12th. The company reported ($0.12) earnings per share for the quarter, topping analysts' consensus estimates of ($0.18) by $0.06. The company had revenue of $510.25 million for the quarter, compared to analysts' expectations of $491.20 million. Clover Health Investments had a negative trailing twelve-month return on equity of 62.58% and a negative net margin of 10.49%.

Who are Clover Health Investments' major shareholders?

Clover Health Investments' stock is owned by many different institutional and retail investors. Top institutional investors include SignalPoint Asset Management LLC (0.03%). Insiders that own company stock include Anna U Loengard, Chamath Palihapitiya, Chelsea Clinton and Lee Shapiro.
View institutional ownership trends
.

How do I buy shares of Clover Health Investments?

Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CLOV) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners